Abstract:Ethnopharmacological relevance Gardenia Fructus ( Gardenia jasminoides Ellis , Zhizi) and Chuanxiong Rhizoma ( Ligusticum chuanxiong Hort. , Chuanxiong) are both traditional Chinese medicines with vascular protective effects, which help detoxify and activate blood, and are clinically used to treat atherosclerosis (AS). Previously, Zhizi-Chuanxiong showed good efficacy in attenuating AS progression in rabbits. However, its potential mechanism is yet unclear. Aim of the study This study aimed to investigate the mechanism of the Zhizi-Chuanxiong herb pair (ZCHP) in attenuating AS progression from the perspective of DNA methylation. Materials and methods An AS mouse model was developed with ApoE −/− mice fed a high-fat diet (HFD). The therapeutic effects and mechanisms of ZCHP in treating HFD-induced AS were identified using an automated biochemical analyzer, enzyme-linked immunosorbent assays, histopathology, methyl-capture sequencing (MC-seq), pyrosequencing, quantitative reverse transcription-polymerase chain reaction (RT-qPCR), western blotting, and TUNEL staining. Results ZCHP attenuated the development of AS by reducing lipid levels and enhancing the stability of plaques and via anti-inflammation. MC-seq and Kyoto Encyclopedia of Genes and Genomes analysis revealed that ZCHP corrected the expressions of both aberrant hypomethylated and hypermethylated genes, which are involved in the mitogen-activated protein kinase (MAPK) signaling pathway. Protein–protein network interaction analysis and molecular docking showed that fibroblast growth factor 3 (FGFR3) and serine/threonine protein kinase (AKT1) were closely related to the MAPK signaling pathway among differentially methylated genes induced by ZCHP. Furthermore, pyrosequencing showed that ZCHP could induce FGFR3 hypermethylation and AKT1 hypomethylation in the promoter region, which was consistent with the MC-seq results. Molecular docking showed that the ZCHP was more tightly docked to FGFR3. Furthermore, RT-qPCR and western blotting showed that the mRNA and protein expression levels of FGFR3 decreased after treatment with ZCHP. Finally, western blotting showed that ZCHP suppressed the expression of phosphorylated MAPK and phosphorylated extracellular signal-regulated kinase (ERK), and TUNEL staining showed that ZCHP treatment could inhibit apoptosis in AS. Conclusion Our findings suggest that ZCHP can effectively attenuate AS progression by inhibiting MAPK/ERK signaling–mediated apoptosis via FGFR3 hypermethylation in the promoter region.

Chromofungin mitigates free fatty acids‐induced endothelial inflammation via inhibition of NOD‐like receptor thermal protein domain‐associated protein 3 mediated by adenosine 5ʹ‐monophosphate‐activated protein kinase

Chromofungin Mitigates Free Fatty Acids-Induced Endothelial Inflammation Via Inhibition of NOD-like Receptor Thermal Protein Domain-Associated Protein 3 Mediated by Adenosine 5′-Monophosphate-activated Protein Kinase

Free fatty acids induce coronary microvascular dysfunction via inhibition of the AMPK/KLF2/eNOS signaling pathway

Folic Acid Delays Development of Atherosclerosis in Low‐density Lipoprotein Receptor‐deficient Mice

Ginsenoside F1 Ameliorates Endothelial Cell Inflammatory Injury and Prevents Atherosclerosis in Mice through A20-Mediated Suppression of NF-kB Signaling.

Ferulic Acid and Protocatechuic Acid Alleviate Atherosclerosis by Promoting UCP1 Expression to Inhibit the NLRP3-IL-1β Signaling Pathway.

Adiponectin improves endothelial dysfunction caused by elevated FFAs levels, partially through cAMP-dependent pathway.

FGF21 induces autophagy‐mediated cholesterol efflux to inhibit atherogenesis via RACK1 up‐regulation

Mechanistic insights into folic acid-dependent vascular protection: dihydrofolate reductase (DHFR)-mediated reduction in oxidant stress in endothelial cells and angiotensin II-infused mice: a novel HPLC-based fluorescent assay for DHFR activity

Complex FFA1 receptor (in)dependent modulation of calcium signaling by free fatty acids

FSCN1 is a Potential Therapeutic Target for Atherosclerosis Revealed by Single-Cell and Bulk RNA Sequencing

Ferulic Acid Inhibits Advanced Glycation End Products (ages) Formation and Mitigates the AGEs-induced Inflammatory Response in HUVEC Cells

Essential oil from Fructus Alpinia zerumbet ameliorates atherosclerosis by activating PPARγ-LXRα-ABCA1/G1 signaling pathway

Zhizi-Chuanxiong herb pair alleviates atherosclerosis progression in ApoE −/− mice by promoting the methylation of FGFR3 to inhibit MAPK/ERK-mediated apoptosis

Possible Role of Fibroblast Growth Factor 21 on Atherosclerosis Via Amelioration of Endoplasmic Reticulum Stress-Mediated Apoptosis in Apoe−/− Mice

Metabolite Neu5Ac triggers SLC3A2 degradation promoting vascular endothelial ferroptosis and aggravates atherosclerosis progression in ApoE -/- mice

Enhanced lipid metabolism reprogramming in CHF rats through IL-6-mediated cardiac glial cell modulation by digilanid C and electroacupuncture stimulation combination

Fucoidan-induced Reduction of Lipid Accumulation in Foam Cells Through Overexpression of Lysosome Genes.

Differential Modulation of Catecholamine and Adipokine Secretion by the Short Chain Fatty Acid Receptor FFAR3 and α2-Adrenergic Receptors in PC12 Cells

Fluorescent gold nanoclusters possess multiple actions against atherosclerosis

Ginsenoside Rg3 Alleviates ox-LDL Induced Endothelial Dysfunction and Prevents Atherosclerosis in ApoE−/− Mice by Regulating PPARγ/FAK Signaling Pathway